Close

Subsidiary of Heat Biologics (HTBX) Receives Second Tranche of $15.2M CPRIT Grant Award

October 30, 2017 8:13 AM EDT Send to a Friend
Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system against cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login